Recent studies have used dynamic contrast MRI with gadolinium-labelled antibodies to markers of immune cell populations may be helpful in providing a non-invasive method of tracking the tumor immune microenvironment following RFA-lip-GM-CSF in future studies [45, 46]. Here, CSF2 is linked to neoplasm.